Clinical Trial Update: Busulfan and Fludarabine in Patients With AML and MDS [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a busulfan and fludarabine regimen in patients with acute myeloid leukemia and myelodysplastic syndrome has completed, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2012-05-15